Cardio Diagnostics Hldgs Inc (CDIO)

May 29, 2025, 8:35 AM EDT - 5 days ago

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

May 20, 2025, 8:35 AM EDT - 14 days ago

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

May 8, 2025, 8:35 AM EDT - 26 days ago

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Mar 26, 2025, 8:31 AM EDT - 2 months ago

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

Feb 4, 2025, 8:31 AM EST - 4 months ago

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Dec 16, 2024, 8:31 AM EST - 6 months ago

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Nov 12, 2024, 8:31 AM EST - 7 months ago

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Oct 1, 2024, 8:31 AM EDT - 8 months ago

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Jul 29, 2024, 8:45 AM EDT - 11 months ago

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Jun 27, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Jun 25, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Jun 10, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

May 21, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

May 13, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week

Apr 29, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually

Apr 9, 2024, 8:31 AM EDT - 1 year ago

Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan

Apr 4, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

Mar 14, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific Session

Mar 5, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Feb 15, 2024, 8:46 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout

Feb 7, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters

Feb 5, 2024, 8:31 AM EST - 1 year ago

Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests

Jan 24, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Jan 8, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Jan 4, 2024, 11:36 AM EST - 1 year ago

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™

Jan 4, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™

Jan 3, 2024, 8:31 AM EST - 1 year ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Jan 2, 2024, 8:31 AM EST - 1 year ago

American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.'s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code

Dec 21, 2023, 9:21 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors

Dec 6, 2023, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement

Dec 4, 2023, 5:38 PM EST - 1 year ago

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 4, 2023, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc's Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 28, 2023, 8:31 AM EST - 1 year ago

American Medical Association is Reviewing Cardio Diagnostics Holdings, Inc's Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes

Nov 20, 2023, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association

Nov 7, 2023, 9:01 AM EST - 1 year ago

Family Medicine Specialists Selects Cardio Diagnostics' Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients

Oct 31, 2023, 9:01 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD

Oct 17, 2023, 9:01 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India

Oct 12, 2023, 8:30 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins

Sep 20, 2023, 9:01 AM EDT - 1 year ago

Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics

Sep 7, 2023, 9:01 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry

Sep 6, 2023, 9:16 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital's Heart Attack Prevention Clinic on Coronary Artery Disease Study

Sep 5, 2023, 9:01 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences

Aug 18, 2023, 8:30 AM EDT - 1 year ago

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

GENE

Aug 2, 2023, 8:30 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application

Jul 6, 2023, 9:05 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas

Jun 21, 2023, 8:45 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD™

Jun 13, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease

May 16, 2023, 10:35 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc's Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management

May 16, 2023, 9:10 AM EDT - 2 years ago

Cardio Diagnostics Holding, Inc's Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management

May 10, 2023, 9:01 AM EDT - 2 years ago

Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio Diagnostics